Age: 79.0
Sex: M
Vaccine: COVID19-2, COVID19-2
Symptoms: Balance disorder, Urinary tract infection
Clinical narrative: UTI/may be tied down to the UTI / very short urination very often/running a fever; he could not get our of his lounge chair, he tried to slip down but could not control any part of his body/some balance issue when he is getting out of his chair; This spontaneous case was reported by a patient and describes the occurrence of URINARY TRACT INFECTION (UTI/may be tied down to the UTI / very short urination very often/running a fever) and BALANCE DISORDER (he could not get our of his lounge chair, he tried to slip down but could not control any part of his body/some balance issue when he is getting out of his chair) in a 79-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7162B) for COVID-19 prophylaxis.    Co-suspect product included non-company product INFLUENZA VACCINE (FLU [INFLUENZA VACCINE]) for an unknown indication.    The patient had never tested or diagnosed COVID positive.  Concurrent medical conditions included Iodine allergy (Betadine), Latex allergy, Type 2 diabetes mellitus, Blood pressure abnormal and Blood cholesterol abnormal. Concomitant products included AMLODIPINE, ACETYLSALICYLIC ACID (BABY ASPIRIN), ATORVASTATIN, BENAZEPRIL, FUROSEMIDE, GABAPENTIN, GLIMEPIRIDE, ISOSORBIDE, SITAGLIPTIN PHOSPHATE (JANUVIA), EMPAGLIFLOZIN (JARDIANCE), INSULIN GLARGINE (LANTUS), METFORMIN, TAMSULOSIN, PARACETAMOL (TYLENOL) and MINERALS NOS;VITAMINS NOS for an unknown indication.   On 21-Sep-2022, the patient received fifth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form and dose of INFLUENZA VACCINE (FLU [INFLUENZA VACCINE]) (unknown route) 1 dosage form. On 22-Sep-2022, the patient experienced URINARY TRACT INFECTION (UTI/may be tied down to the UTI / very short urination very often/running a fever). 22-Sep-2022, the patient experienced BALANCE DISORDER (he could not get our of his lounge chair, he tried to slip down but could not control any part of his body/some balance issue when he is getting out of his chair). The patient was treated with CEFDINIR on 22-Sep-2022 for Fever, at a dose of 300 milligram twice a day and IBUPROFEN (MOTRIN [IBUPROFEN]) at a dose of 1 dosage form. At the time of the report, URINARY TRACT INFECTION (UTI/may be tied down to the UTI / very short urination very often/running a fever) and BALANCE DISORDER (he could not get our of his lounge chair, he tried to slip down but could not control any part of his body/some balance issue when he is getting out of his chair) was resolving.            Concomitant medication included Neuravite once a day.  The patient received his 1st dose on 18-Jan-2021 (lot number-not recorded), 2nd dose on 16-Feb-2021 (lot number-007M20A), 1st booster dose on 04-Nov-2021 (lot number-053E21A), 2nd booster dose on 11-May-2022 (lot number-066K21A).  On 21Sep2022, patient got the bivalent booster dose at around 11:00am and within an hour had the flu shot. At approximately 10:00pm that evening, patient could not get out of the lounge chair and tried to slip down but could not control any part of the body. At around 5:00-5:30am on 22Sep2022, the patient was taken to the emergency room (ER). The paperwork in the ER said patient had UTI and that these side effects were due to the combination of the Covid shot and the flu shot. Patient stayed in the ER for 4 hours and was sent home. Now having some balance issue when patient was getting out of chair which may be tied down to the UTI.  Patient also reported "very short urination very often" and the urologist was looking to find some issues with prostate. The patient was now moving  little slow from all that went down with this problems stated this was a major anomaly from the combination of the 2 shots.  The patient did not experience a similar event in the past.